Elizabeth E Evans

Summary

Publications

  1. ncbi C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
    Elizabeth E Evans
    Vaccinex, Inc, Rochester, 1875 Mt Hope Avenue, Rochester, NY 14620, USA
    Mol Cancer Ther 5:2919-30. 2006
  2. doi SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
    Ernest S Smith
    Vaccinex, Inc, Rochester, NY 14620, USA
    Neurobiol Dis 73:254-68. 2015

Collaborators

  • Ernest S Smith
  • Christine Reilly
  • Chad Cornelius
  • Damir Janigro
  • Sebold Torno
  • Trinh Pham
  • Renee Kirk
  • Terrence Fisher
  • John E Leonard
  • Alan Howell
  • Alan Jonason
  • Holm Bussler
  • Mark Paris
  • Crystal Mallow
  • Jennifer Seils
  • Nicola Marchi
  • William J Bowers
  • Michael Doherty
  • Gareth John
  • Ekaterina Klimatcheva
  • Janaki Veeraraghavan
  • Azeb Tadesse Argaw
  • Maurice Zauderer

Detail Information

Publications2

  1. ncbi C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
    Elizabeth E Evans
    Vaccinex, Inc, Rochester, 1875 Mt Hope Avenue, Rochester, NY 14620, USA
    Mol Cancer Ther 5:2919-30. 2006
    ....
  2. doi SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
    Ernest S Smith
    Vaccinex, Inc, Rochester, NY 14620, USA
    Neurobiol Dis 73:254-68. 2015
    ....